126 related articles for article (PubMed ID: 1998678)
21. Interligand Overhauser effects in type II dihydrofolate reductase.
Li D; Levy LA; Gabel SA; Lebetkin MS; DeRose EF; Wall MJ; Howell EE; London RE
Biochemistry; 2001 Apr; 40(14):4242-52. PubMed ID: 11284680
[TBL] [Abstract][Full Text] [Related]
22. Refolding of [6-19F]tryptophan-labeled Escherichia coli dihydrofolate reductase in the presence of ligand: a stopped-flow NMR spectroscopy study.
Hoeltzli SD; Frieden C
Biochemistry; 1998 Jan; 37(1):387-98. PubMed ID: 9425060
[TBL] [Abstract][Full Text] [Related]
23. Role of aspartate 27 in the binding of methotrexate to dihydrofolate reductase from Escherichia coli.
Appleman JR; Howell EE; Kraut J; Kühl M; Blakley RL
J Biol Chem; 1988 Jul; 263(19):9187-98. PubMed ID: 3288632
[TBL] [Abstract][Full Text] [Related]
24. NMR studies of differences in the conformations and dynamics of ligand complexes formed with mutant dihydrofolate reductases.
Birdsall B; Andrews J; Ostler G; Tendler SJ; Feeney J; Roberts GC; Davies RW; Cheung HT
Biochemistry; 1989 Feb; 28(3):1353-62. PubMed ID: 2496755
[TBL] [Abstract][Full Text] [Related]
25. Dynamics of a flexible loop in dihydrofolate reductase from Escherichia coli and its implication for catalysis.
Falzone CJ; Wright PE; Benkovic SJ
Biochemistry; 1994 Jan; 33(2):439-42. PubMed ID: 8286374
[TBL] [Abstract][Full Text] [Related]
26. Conformational changes in the active site loops of dihydrofolate reductase during the catalytic cycle.
Venkitakrishnan RP; Zaborowski E; McElheny D; Benkovic SJ; Dyson HJ; Wright PE
Biochemistry; 2004 Dec; 43(51):16046-55. PubMed ID: 15609999
[TBL] [Abstract][Full Text] [Related]
27. Neutron diffraction studies of Escherichia coli dihydrofolate reductase complexed with methotrexate.
Bennett B; Langan P; Coates L; Mustyakimov M; Schoenborn B; Howell EE; Dealwis C
Proc Natl Acad Sci U S A; 2006 Dec; 103(49):18493-8. PubMed ID: 17130456
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of the importance of hydrophobic interactions in drug binding to dihydrofolate reductase.
Taira K; Benkovic SJ
J Med Chem; 1988 Jan; 31(1):129-37. PubMed ID: 3275776
[TBL] [Abstract][Full Text] [Related]
29. Carbon-13 nuclear magnetic resonance study of protonation of methotrexate and aminopterin bound to dihydrofolate reductase.
Cocco L; Groff JP; Temple C; Montgomery JA; London RE; Matwiyoff NA; Blakley RL
Biochemistry; 1981 Jul; 20(14):3972-8. PubMed ID: 7284303
[TBL] [Abstract][Full Text] [Related]
30. Structures of dihydrofolate reductase-thymidylate synthase of Trypanosoma cruzi in the folate-free state and in complex with two antifolate drugs, trimetrexate and methotrexate.
Senkovich O; Schormann N; Chattopadhyay D
Acta Crystallogr D Biol Crystallogr; 2009 Jul; 65(Pt 7):704-16. PubMed ID: 19564691
[TBL] [Abstract][Full Text] [Related]
31. Contributions of tryptophan 24 and glutamate 30 to binding long-lived water molecules in the ternary complex of human dihydrofolate reductase with methotrexate and NADPH studied by site-directed mutagenesis and nuclear magnetic resonance spectroscopy.
Meiering EM; Li H; Delcamp TJ; Freisheim JH; Wagner G
J Mol Biol; 1995 Mar; 247(2):309-25. PubMed ID: 7707377
[TBL] [Abstract][Full Text] [Related]
32. Dihydrofolate reductase: control of the mode of substrate binding by aspartate 26.
Jimenez MA; Arnold JR; Andrews J; Thomas JA; Roberts GC; Birdsall B; Feeney J
Protein Eng; 1989 Aug; 2(8):627-31. PubMed ID: 2813337
[TBL] [Abstract][Full Text] [Related]
33. Interpretation of nuclear magnetic resonance spectra for Lactobacillus casei dihydrofolate reductase based on the X-ray structure of the enzyme-methotrexate-NADPH complex.
Matthews DA
Biochemistry; 1979 Apr; 18(8):1602-10. PubMed ID: 34432
[TBL] [Abstract][Full Text] [Related]
34. Solution structure of bound trimethoprim in its complex with Lactobacillus casei dihydrofolate reductase.
Martorell G; Gradwell MJ; Birdsall B; Bauer CJ; Frenkiel TA; Cheung HT; Polshakov VI; Kuyper L; Feeney J
Biochemistry; 1994 Oct; 33(41):12416-26. PubMed ID: 7918464
[TBL] [Abstract][Full Text] [Related]
35. Functional role of a mobile loop of Escherichia coli dihydrofolate reductase in transition-state stabilization.
Li L; Falzone CJ; Wright PE; Benkovic SJ
Biochemistry; 1992 Sep; 31(34):7826-33. PubMed ID: 1510968
[TBL] [Abstract][Full Text] [Related]
36. Histidine hydrogen-deuterium exchange mass spectrometry for probing the microenvironment of histidine residues in dihydrofolate reductase.
Miyagi M; Wan Q; Ahmad MF; Gokulrangan G; Tomechko SE; Bennett B; Dealwis C
PLoS One; 2011 Feb; 6(2):e17055. PubMed ID: 21359214
[TBL] [Abstract][Full Text] [Related]
37. NMR solution structure of the antitumor compound PT523 and NADPH in the ternary complex with human dihydrofolate reductase.
Johnson JM; Meiering EM; Wright JE; Pardo J; Rosowsky A; Wagner G
Biochemistry; 1997 Apr; 36(15):4399-411. PubMed ID: 9109647
[TBL] [Abstract][Full Text] [Related]
38. Dihydrofolate reductase from a methotrexate-resistant Escherichia coli: proton magnetic resonance studies of complexes with folate and methotrexate.
Poe M; Williams MN; Greenfield NJ; Hoogsteen K
Biochem Biophys Res Commun; 1975 Nov; 67(1):240-7. PubMed ID: 1012
[No Abstract] [Full Text] [Related]
39. Circular dichroism studies of dihydrofolate reductase from a methotrexate-resistant strain of Escherichia coli B, MB 1428: ternary complexes.
Greenfield NJ
Biochim Biophys Acta; 1975 Sep; 403(1):32-46. PubMed ID: 240430
[TBL] [Abstract][Full Text] [Related]
40. 31P-NMR assignment and conformational study of NADPH bound to Lactobacillus casei dihydrofolate reductase based on two-dimensional 1H-31P-heteronuclear and 1H-detected 1H-31P-shift-correlation experiments.
Gerothanassis IP; Birdsall B; Bauer CJ; Feeney J
Eur J Biochem; 1992 Feb; 204(1):173-7. PubMed ID: 1740127
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
